as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 28 Oct 2026
₹26.66
Change
+0.9 (3.49%)
Open
₹26.04
Prev. Close
₹25.76
Day High
₹27.0
Day Low
₹26.04
Volume Analysis
Traded
1,531,216
Delivered
1,457,905
Delivery %
95.21%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹28.06 | ₹27.53 | ₹27.1 | ₹26.57 | ₹26.14 | ₹25.61 | ₹25.18 |
| Fibonacci | ₹27.53 | ₹27.16 | ₹26.94 | ₹26.57 | ₹26.2 | ₹25.98 | ₹25.61 |
| Camarilla | ₹26.92 | ₹26.84 | ₹26.75 | ₹26.57 | ₹26.57 | ₹26.48 | ₹26.4 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
—
1 Week
—
1 Month
—
3 Months
—
6 Months
—
1 Year
—
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Source: Screener.in (Standalone figures) — data as of 28 Oct 2026. Not investment advice.
TopFund Analysis
Icicipramc - Pharmaietf lands in the middle of the pack on TopFund's composite fundamentals check, at 59/100. This read is based on 52/100 data confidence — some factors are missing or the underlying data is dated, so treat this as a partial picture rather than a complete one.
TopFund Score — Fundamentals Quality
59/100 — AverageData confidence: 52/100 (Low Confidence) — based on how complete and how fresh the underlying data is.
As of 28 Oct 2026 · How we calculate this →
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Which Mutual Funds Hold Icicipramc - Pharmaietf?
Frequently Asked Questions about Icicipramc - Pharmaietf
Icicipramc - Pharmaietf (PHARMAIETF) closed at ₹26.66 on NSE on 28 October 2026, up 0.9 (3.49%) from the previous close.
Icicipramc - Pharmaietf trades on the NSE (National Stock Exchange of India) under the symbol PHARMAIETF.
Icicipramc - Pharmaietf has a TopFund Quality Score of 59/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Icicipramc - Pharmaietf?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.